| 治疗乙肝新药物的研究进展与评价 |
| |
| 引用本文： | 翁水旺,沈诗景.治疗乙肝新药物的研究进展与评价[J].海峡药学,2010,22(12):101-103. |
| |
| 作者姓名： | 翁水旺 沈诗景 |
| |
| 作者单位： | 福建省药品检验所,福州,350001 |
| |
| 摘 要： | 了解治疗乙肝新药物的研究进展。方法采用国内外文献综述方法。结果新药拉米夫定、阿德福韦和恩替卡韦有抑制乙肝病毒作用。结论它们的联合应用有很强的抗乙肝病毒效果。
|
| 关 键 词： | 新药 拉米夫定、阿德福韦和恩替卡韦 抗乙肝病毒 |
Evaluation and development of new drugs against Hepatitis B Virus |
| |
| WENG Shui-wang,SHEN Shi-jing.Evaluation and development of new drugs against Hepatitis B Virus[J].Strait Pharmaceutical Journal,2010,22(12):101-103. |
| |
| Authors: | WENG Shui-wang SHEN Shi-jing |
| |
| Institution: | (Fujian Provincial Institute for Drug Control,Fuzhou 350001,China) |
| |
| Abstract: | OBJECTIVE To investigate Development of new drugs against Hepatitis B Virus.METHODS Literature both home and abroad was reviewed.RESULTS There were inhibits HBV in the new drugs of lamivudine,adefovir and enticavir.CONCLUSION Combination of the new drugs has sound effects against Hepatitis B Virus. |
| |
| Keywords: | New drugs Lamivudine Adefovir and enticavir Against Hepatitis B Virus |
| 本文献已被 维普 万方数据 等数据库收录！ |
